Current Research and Future Trends Expanding Clinical Applications Ongoing studies are exploring the role of AOD-9604 in treating metabolic conditions such as: Type 2 diabetes Insulin resistance Non-alcoholic fatty liver disease (NAFLD) Up to 95% of individuals with type 2 diabetes also present with NAFLD, emphasizing the need for multi-functional metabolic therapies Joint Health & Cartilage Regeneration In addition to fat metabolism, AOD-9604 may stimulate cartilage repair and support joint health
Communications Telephone communications with us, including calls with any of our agents are routinely monitored and/or recorded
Oh R, Brown DL
Menstrual disorders, Cushingoid state, growth retardation in children, adrenal insufficiency, which especially develops during stressful situations such as trauma, surgery, or systemic diseases
Fat: 0.3-0.5 grams per pound of body weight
It does not appear to affect blood sugar or IGF-1: research suggests it promotes fat breakdown without the glucose effects associated with full growth hormone